Latest News and Press Releases

BOSTON, April 01, 2026 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced that, effective on...

CAMBRIDGE, Mass., April 01, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease,...

Consumer interest surges around Purisaki Berberine Patches as questions about ingredients, transdermal delivery, and company details increase.

Slim Boost Tea 2026 report: COMT enzyme claims, 14 detox tea ingredients, all-day metabolism positioning, pricing, and what to know before buying

BIOptimizers Magnesium Breakthrough 2026: 7-form magnesium supplement facts, sleep and stress research context, pricing, and key buyer details.

MOUNTAIN VIEW, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life-sciences company developing innovative targeted oncology therapies and...

HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm

New York, USA, April 01, 2026 (GLOBE NEWSWIRE) -- Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry |...

LOS ANGELES, April 01, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...

BROSSARD, Québec, 01 avr. 2026 (GLOBE NEWSWIRE) -- Diagnos inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK, OTCQB : DGNOF, FWB : 4D4A), une entreprise dédiée à la détection...

BROSSARD, Quebec, April 01, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Atara To Contact Him Directly To Discuss Their Options If you purchased or...

SOUTH JORDAN, Utah, April 01, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced it has acquired View Point Medical, Inc....

GARDEN CITY, N.Y., April 01, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide...

ATLANTA, April 01, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and...

Lausanne, Switzerland, April 01, 2026 (GLOBE NEWSWIRE) -- Distalmotion, the global MedTech company expanding access to robotic surgery in outpatient sites of care, announced that it submitted a...

SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, today announced...

CHARLOTTE, N.C., April 01, 2026 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) is proud to celebrate a decade of partnership with Burn Boot Camp, a leading boutique fitness franchise,...

Paragonix Technologies will feature oral presentations and poster sessions at ISHLT 2026, showcasing clinical data related to its heart and lung preservation devices.The extensive research being...

CALABASAS, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company developing...

SYDNEY, April 01, 2026 (GLOBE NEWSWIRE) -- Actinogen Medical Limited (ASX: ACW) announces that the first participant has been treated in the open-label extension (OLE) phase of the XanaMIA trial...

WESTMINSTER, Colo., April 01, 2026 (GLOBE NEWSWIRE) -- Highridge Medical, a leading privately held global spine company with a portfolio supported by extensive clinical evidence, announced that,...

SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS), (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety,...

TORONTO, April 01, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a...

IRVINE, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy® Transcatheter Heart Valve (THV) System, today announced the successful first...

SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic...

Chang Robotics Fund adds five new investments, doubling its portfolio to 10 companies across healthcare, energy, robotics, and advanced manufacturing.

Distribution agreement to enhance channel partner expansion across five U.S. states The collaboration is expected to support adoption of advanced 3D imaging within orthopedic practices and surgical...

TUCSON, Ariz., April 01, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the “Company”), parent company of SynCardia Systems LLC (“SynCardia”), maker of the world’s first total...

Bezuclastinib NDA submitted under the FDA’s RTOR program based on positive results from Phase 3 PEAK trial; bezuclastinib previously granted Breakthrough Therapy Designation in GISTBezuclastinib...

PHILADELPHIA, April 01, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development...

Trevi Therapeutics to host an Investor and Analyst Day on May 7th in NYC and participate in key upcoming events.

GARDian3 trial enrollment and dosing completed (N=63) in less than nine monthsTopline results expected in 2Q27 with BLA to follow by mid-2027OCU410ST represents a potential first-in-class, one-time...

Dublin, April 01, 2026 (GLOBE NEWSWIRE) -- The "Mammography Workstation Market Report 2026" has been added to ResearchAndMarkets.com's offering. The mammography workstation market has witnessed...

Pasithea Therapeutics Announces Grant of Fast Track Designation by FDA to PAS-004 for Treatment of NF1 Associated Plexiform Neurofibromas

Axsome obtains exclusive global rights to balipodect, a potentially first-in-class selective phosphodiesterase 10A inhibitor Acquisition further expands Axsome’s industry-leading CNS portfolio with a...

Company intends to uplist to a national securities exchange in 2026 COSTA MESA, CA, April 01, 2026 (GLOBE NEWSWIRE) -- Charlie’s Holdings, Inc. (OTCQB: CHUC) (“Charlie’s” or the “Company”), an...

PDUFA target action date of November 14, 2026 Potential first FDA-approved treatment option for the acute treatment of agitation associated with bipolar disorders or schizophrenia in the at-home...

BEDFORD, Mass., April 01, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today...

TORONTO, April 01, 2026 (GLOBE NEWSWIRE) -- Kala Bio Inc. (NASDAQ: KALA), a clinical-stage biopharmaceutical company at the forefront of artificial intelligence and cell and gene therapy innovation,...

Dublin, April 01, 2026 (GLOBE NEWSWIRE) -- The "Gemcitabine Hydrochloride Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report provides detailed statistics on global...

Dublin, April 01, 2026 (GLOBE NEWSWIRE) -- The "Liposomal Doxorubicin Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report provides comprehensive insights into...

Austin, April 01, 2026 (GLOBE NEWSWIRE) -- The Microcrystalline Cellulose Market size was estimated at USD 1.30 billion in 2025 and is expected to reach USD 2.61 billion by 2035, growing at a CAGR...

BudPop earns top THCP gummy ranking in 2026 after independent reviewers tested 40+ brands on potency accuracy, lab verification, and ingredient quality.

VANCOUVER, British Columbia, April 01, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse...

Protein chip market grows to USD 4.79 Billion by 2035 at 6.89% CAGR, driven by proteomics research, and rising clinical diagnostics adoption.

Dublin, April 01, 2026 (GLOBE NEWSWIRE) -- The "Outpatient Oncology Infusion Market Report 2026" has been added to ResearchAndMarkets.com's offering. The outpatient oncology infusion market is...

Dublin, April 01, 2026 (GLOBE NEWSWIRE) -- The "Oncology Ablation Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report offers comprehensive statistics, market size...

Dublin, April 01, 2026 (GLOBE NEWSWIRE) -- The "Advanced Renal Cell Carcinoma Treatment Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report outlines...

Dublin, April 01, 2026 (GLOBE NEWSWIRE) -- The "Avastin (Bevacizumab) Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ...